Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
VectivBio and Asahi Kasei Pharma Announce the Start of a Phase 1 Study of Apraglutide in Japan
VectivBio, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, and Asahi […]
Cell One Partners and Center for Breakthrough Medicines Announce Strategic Partnership to Accelerate Cell and Gene Therapy Commercialization
Cell One Partners, an industry-leading strategic consulting firm positioned to support cell and gene therapy […]
Aldevron and Evanoa Sign Licensing Agreement
Evanoa Bioscience, a cell line developer for biologics manufacturing, together with Aldevron, a global leader […]
QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug
QIAGEN today announced it has entered into a strategic partnership with Servier, a global pharmaceutical […]
Korro Bio and Genevant Sciences Enter into Collaboration Agreement to Develop RNA Editing Therapeutic for Alpha-1 Antitrypsin Deficiency
Korro Bio, a leading RNA editing company focused on the discovery and development of novel […]
Biocytogen Announces RenLite™ Licensing Agreement with Janssen
Biocytogen Pharmaceuticals, have announced the signing of a non-exclusive license agreement with Janssen Biotech, one […]
Cantex and Miami Cancer Institute Announce FDA Clearance for a Clinical Trial Investigating Azeliragon Combined with Stereotactic Radiosurgery for the Treatment of Brain Metastases
Cantex Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other […]
Cardinal Health's Outcomes™ Collaborates with Signify Health to Offer In-Home Medication Therapy Management
Cardinal Health today announced its collaboration with Signify Health to offer in-home clinical and medication management […]
Illumina and Myriad Genetics Expand Partnership to Broaden Access to HRD Testing in the United States
Illumina, a global leader in DNA sequencing and array-based technologies, and Myriad Genetics, a leader […]
Porton Advanced Collaborates with DanausGT to Accelerate the Development of Gene and Cell Therapy
Porton Advanced and DanausGT Biotechnology have announced a strategic collaboration in gene and cell therapy […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more